MediciNova, Inc.
MNOV
$1.79
$0.042.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 920.40K | 596.60K | 409.60K | 257.90K | 134.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 920.40K | 596.60K | 409.60K | 257.90K | 134.60K |
| Cost of Revenue | 573.10K | 548.70K | 378.60K | 231.60K | 116.30K |
| Gross Profit | 347.50K | 48.00K | 31.10K | 26.30K | 18.30K |
| SG&A Expenses | 6.78M | 6.39M | 6.16M | 5.88M | 5.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.77M | 13.51M | 13.69M | 13.63M | 13.44M |
| Operating Income | -11.85M | -12.92M | -13.28M | -13.37M | -13.30M |
| Income Before Tax | -10.75M | -11.71M | -11.99M | -12.00M | -11.81M |
| Income Tax Expenses | 6.00K | 6.00K | 6.00K | 5.50K | 5.50K |
| Earnings from Continuing Operations | -10.75 | -11.72 | -12.00 | -12.01 | -11.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.75M | -11.72M | -12.00M | -12.01M | -11.81M |
| EBIT | -11.85M | -12.92M | -13.28M | -13.37M | -13.30M |
| EBITDA | -11.83M | -12.90M | -13.26M | -13.35M | -13.28M |
| EPS Basic | -0.22 | -0.24 | -0.24 | -0.24 | -0.24 |
| Normalized Basic EPS | -0.14 | -0.15 | -0.15 | -0.15 | -0.15 |
| EPS Diluted | -0.22 | -0.24 | -0.24 | -0.24 | -0.24 |
| Normalized Diluted EPS | -0.14 | -0.15 | -0.15 | -0.15 | -0.15 |
| Average Basic Shares Outstanding | 196.60M | 196.43M | 196.43M | 196.36M | 196.36M |
| Average Diluted Shares Outstanding | 196.60M | 196.43M | 196.43M | 196.36M | 196.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |